Not exact matches
Brad Spellberg's research interests are diverse, ranging from basic immunology and vaccinology, to pure
clinical and
outcomes research, to process
improvement work related to delivery of care, focusing
on safety net hospitals.
â $ œFor the first time, a
clinical trial has shown that administration of a cellular therapeutic results in an
improvement in cardiac
outcomes based
on a prespecified analysis, â $ an editorial accompanying the paper in The Lancet says.
A schematic representation summarizing these
improvements, the effects
on clinical outcomes and proposed mechanisms, is presented in Figure 1.
UACIM research activities contribute rigorous scientific studies
on the integration of complementary therapies with conventional medicine, with a focus
on educational research, corporate health
improvement research, and methods to study
clinical outcomes in integrative medicine.
Although short - term randomized
clinical trials have shown a beneficial effect of high protein intake, 3,4,20,21 the long - term health consequences of protein intake remain controversial.8,9,22 - 25 In a randomized
clinical trial with a 2 - year intervention, 4 calorie - restricted diets with different macronutrient compositions did not show a difference in the effects
on weight loss or
on improvement of lipid profiles and insulin levels.26 When protein is substituted for other macronutrients, the dietary source of protein appears to be a critical determinant of the
outcome.
Collaborates with the
Clinical Director, Vice President of Nursing and Chief Nursing Officer on quality, performance improvement and clinical o
Clinical Director, Vice President of Nursing and Chief Nursing Officer
on quality, performance
improvement and
clinical o
clinical outcomes.
Primary
outcome: treatment response defined variably; number of patients with at least a 50 % reduction from baseline score
on a condition relevant scale: the Hamilton Anxiety Scale for generalised anxiety disorder (GAD), the Panic Disorder Severity Scale or the Sheehan Panic Anxiety Scale — Patient for panic disorder, the Brief Social Phobia Scale or the Liebowitz Social Anxiety Scale for social phobia or a
Clinical Global Impressions —
Improvement (CGI - I) score of 1 or 2.
The primary
outcome was
clinical response defined using a global rating scale (eg, «much improved» or «very much improved» on the Clinical Global Impression Scale (CGI)-RRB- or a set level of improvement on a continuous depression rating scale (eg, improvement of 50 % or greater from baseline to end of treatment on the Hamilton Depression Rating Scale (HAMD) or the Montgomery — Asberg Depression Rating Scale (MADR
clinical response defined using a global rating scale (eg, «much improved» or «very much improved»
on the
Clinical Global Impression Scale (CGI)-RRB- or a set level of improvement on a continuous depression rating scale (eg, improvement of 50 % or greater from baseline to end of treatment on the Hamilton Depression Rating Scale (HAMD) or the Montgomery — Asberg Depression Rating Scale (MADR
Clinical Global Impression Scale (CGI)-RRB- or a set level of
improvement on a continuous depression rating scale (eg,
improvement of 50 % or greater from baseline to end of treatment
on the Hamilton Depression Rating Scale (HAMD) or the Montgomery — Asberg Depression Rating Scale (MADRS)-RRB-.
For both treatment conditions,
improvements from pre - to posttreatment were seen for all of the
clinical -
outcome measures, including the Drug Abuse Score
on the PSS.
Behavioral health providers, in addition to providing
clinical services, administrative duties, and perhaps supervision / teaching, may be asked to design evaluations, analyze findings, and present
on or publish the
outcomes from program development and process
improvement studies.